
Saturday, March 03, 2018 12:40:09 AM
As a shareholder with Over 1M shares, I do believe they are withholding something. The leak out agreements have to stand for something, the free and clear patents have to stand for something, the announcement of "working with the FDA has to stand for something, the one day "public offering that was only offered to SELECT ROTH INVESTORS has to stand for something too.
My opinion only, but if it walks like a duck, and quacks like a duck....it is probably a duck!
The share price was going up after all the positive announcements... then an ugly announcement of capital raise...we all figured it would be at .04 ..... then the open/close announcement came out that they sold shares and warrants at .02? Why? Because someone knows something, and is not letting on. With the latest announcement from the company of having to increase shares and immediately R/S, they are afraid of something!
Honestly, it sounds like a bid from "someone"...to take over! If not a complete ownership, then acquiring enough shares to have a significant vote at the table...( See how SoftBank is "running" Sprint...with 49% of the issued shares... the T-mobile deal was killed because SoftBank said NO!).
I see something here brewing and no one wants to address the proverbial ELEPHANT in the room! DCTH knows it, and they want to wipe out the chances of it happening by doing a R/S and then increasing share count again to make whomever is accumulating have only a minority stake.
So, I would not be the least bit surprised after the Q-1 filings to hear that some entity has a majority position. The shares that have been dumped over the last couple weeks may very well be getting bought by that same entity that bought at .02 just a short time ago....now getting shares even cheaper.
SO YES...to answer that question... I DO THINK THEY HAVE NEWS TO RELEASE! THEY JUST DONT WANT TO BECAUSE THEY ARE TRYINYG TO FIGURE OUT HOW TO THWART IT BEFORE THEY HAVE TO REPORT IT.
Coincidences happen, but this would be the Queen Mother of all coincidences if this is the case!
IMHO
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent DCTH News
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 03/31/2023 03:32:01 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/30/2023 01:00:54 PM
- Delcath Systems Announces Closing of Private Placement of up to $85 Million • PR Newswire (US) • 03/30/2023 01:41:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/28/2023 10:04:20 AM
- Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update • PR Newswire (US) • 03/27/2023 12:20:00 PM
- Delcath Systems Announces up to $85 Million Financing • PR Newswire (US) • 03/27/2023 12:15:00 PM
- Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023 • PR Newswire (US) • 03/27/2023 12:10:00 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/27/2023 12:00:48 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 02/27/2023 10:00:16 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/24/2023 11:08:32 AM
- Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial Launch • PR Newswire (US) • 02/16/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/14/2023 03:59:47 PM
- Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit • PR Newswire (US) • 02/14/2023 01:49:00 PM
- Delcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16 • PR Newswire (US) • 01/30/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/23/2023 12:01:47 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:04 AM
- Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology • PR Newswire (US) • 01/17/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/10/2023 09:13:57 PM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 01/10/2023 09:08:24 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 12/29/2022 10:28:09 PM
- Tender Offer Statement by Issuer (sc To-i) • Edgar (US Regulatory) • 12/21/2022 05:18:41 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 12/16/2022 10:07:45 PM
- Delcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4) • PR Newswire (US) • 12/16/2022 09:15:00 PM
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 12/16/2022 08:04:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/16/2022 02:32:48 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM